This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Cefo Co., Ltd. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Suwon-si Gyeonggi-do, KR (2019)
- Suwon-si, KR (2020)
Company Filing History:
Years Active: 2019-2020
Title: Seol Chu: Innovator in Three-Dimensional Cell Culture Technologies
Introduction
Seol Chu is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the field of cell culture technology, particularly in the development of innovative methods that enhance the efficiency and effectiveness of cell growth and differentiation.
Latest Patents
Seol Chu holds 2 patents that focus on advanced cell culture systems. His latest patents include a "Three-dimensional cell culture system and cell culture method using same," which provides a method for culturing cells in a non-contact manner using a biodegradable synthetic hydrogel. This method is particularly beneficial for stem cells and primary cells, allowing for improved growth conditions. Another notable patent is the "Method for inducing three-dimensional osteogenic differentiation of stem cells using hydrogel." This invention relates to a short-time osteogenic differentiation method that significantly reduces the induction period compared to conventional methods, while also facilitating the easy separation of cells after differentiation.
Career Highlights
Seol Chu is currently associated with Cefo Co., Ltd., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in regenerative medicine and tissue engineering.
Collaborations
Seol Chu collaborates with talented individuals such as Sun Ray Lee and Ji Won Yang, contributing to a dynamic research environment that fosters innovation and development in cell culture technologies.
Conclusion
Seol Chu's contributions to the field of cell culture are noteworthy, and his innovative patents reflect his commitment to advancing biotechnology. His work has the potential to significantly impact medical research and applications in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile